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 Abstract 
 
Background 
There is marked variation in diabetes outcomes for children and adolescents across the UK. 
We used modelling techniques to examine the independent contributions of deprivation, 
ethnicity, insulin pump use and health service use on HbA1c trajectories across adolescence.  
Methods 
Prospective data from a large UK Paediatric & Adolescent Diabetes Service on subjects with 
type 1 diabetes (T1D) aged 9-17 years from January 2008 to December 2013:  2560 HbA1c 
datapoints were available on 384 patients (193 (50.4%) female).  
Sequential multilevel growth models assessed the effects of sex, duration of diabetes, 
deprivation, ethnicity, insulin pump use and health service use on HbA1c. Growth mixture 
models were used to identify discrete HbA1c trajectories across adolescence. 
Results 
Mean clinic HbA1c decreased from 2008 to 2013 by 0.122% (95% CI: 0.034, 0.210; p=0.007) 
per year. The optimal multilevel growth model showed mean HbA1c  increased with age 
(B=0.414, p<0.0001), and that mean HbA1c was predicted by white/British ethnicity (B=-
0.748, p=0.004), clinic visits (B=0.041, p=0.04) and pump use (B=-0.568, p<0.0001) but not 
deprivation.  
The optimal mixture model was a 4 trajectory group solution, with 45.1% in Good Control, 
39.6% with Deteriorating Control, 6.5% with Rapidly Deteriorating Control and 8.8% in Poor 
Control across adolescence. 
Only pump use predicted trajectory group membership, being protective against 
membership of all other trajectories compared with Good Control.  
Conclusions 
Increasing uptake of insulin pumps and ensuring access to health services are likely to be the 
most effective means of reducing inequalities in outcomes of T1D in children and young 
people. 
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Introduction 
The high level of geographical variation and inequality in diabetes outcomes for children and 
young people in the UK is an increasing public health and clinical concern.(1, 2) It is unclear 
whether this variation reflects sociodemographic differences in populations or reflects 
variation in healthcare provision, or both.  
Socioeconomic deprivation has been identified as a predictor of poor glycaemic control in a 
number of studies,(3-8) although others do not report an association,(9, 10) including large 
population-based studies.(11)  Ethnicity is a strong predictor of diabetes control; in the 
2011-12 National Paediatric Diabetes Audit for England and Wales, young people of black 
ethnicity were less likely to achieve diabetes control targets (HbA1c <(58mmol/mol (7.5%)) 
than white young people.(12) A number of other studies have suggested that black and 
minority ethnicity (BME) young people have poorer HbA1c outcomes(4-6, 8, 10) but it 
remains unclear whether this largely reflects deprivation in BME groups(10) or whether non-
white ethnicity confers some disadvantage over and above deprivation.(13) One postulated 
mechanism for deprivation or ethnicity to impact upon glycaemic control is through low 
access to intensive insulin therapies, with evidence that both non-white ethnicity(10) and 
deprivation(8) are associated with poorer initiation of insulin pump therapy.  As insulin 
pump use remains highly variable in the UK, access to pump therapy may be a potent source 
of unwarranted healthcare related variation in HbA1c outcomes. 
Studies have thus far been cross-sectional or short-term,(4) and have not examined the 
independent contributions of ethnicity, deprivation and healthcare factors to variation in 
glycaemic control. None have used developmental trajectory analyses to examine the 
impacts of these factors on the development of inequalities in HbA1c from childhood through 
adolescence.  
The increase in HbA1c from childhood to adolescence in type 1 diabetes (T1D) is well 
described,(14, 15) and reflects the insulin insensitivity of puberty together with the 
psychosocial transitions of adolescence. However, there may in fact be a number of 
different developmental trajectories for HbA1c from childhood through adolescence, 
potentially influenced by biological, social and psychological characteristics and potentially 
amenable to different intervention strategies. The last 20 years has seen the rapid 
development of statistical methods to study developmental trajectories.(16) The first is 
multilevel growth models which identify average trends over time and capture individual 
departures from the average trend, something that standard regression models cannot. 
However, like standard regression models, growth models assume that individuals are 
drawn from the same population and that development over time can be mapped using one 
set of parameters. In contrast, group-based trajectory models or growth mixture models 
allow for the possibility that there may be different sub-populations following different 
developmental trajectories.(16) In diabetes, for example, clinicians might observe that some 
adolescents keep good control throughout the teenage years while in others control 
deteriorates markedly. However this issue has previously been difficult to study. A very small 
number of studies have begun to apply these methods to study the effects of psychosocial 
characteristics on developmental trajectories in HbA1c.(17-19) The effects of ethnicity, 
deprivation, initiation of insulin pump and health service use on HbA1c trajectories have not 
been studied.  
We used a large longitudinal dataset from a high-performing regional specialist child and 
adolescent diabetes clinic which draws patients from across much of south-east England. We 
first used multi-level models for change to examine the influence of deprivation, ethnicity, 
initiation of insulin pump use and health service use on the average HbA1c trajectory from 
childhood through adolescence. We then used growth mixture models to assess whether 
there were identifiable discrete trajectories of HbA1c change in the sample, and examine 
whether deprivation, ethnicity, insulin pump use and health service use influenced 
trajectory membership.  
 
  
Methods 
Data were obtained from the clinical database of the University College Hospital Paediatric 
& Adolescent Diabetes Service. Data were routinely collected prospectively at each clinic 
visit from January 2008 to December 2013 as part of routine ongoing service evaluation and 
for participation in national audits. At each clinic visit, the treating clinician recorded HbA1c 
and insulin treatment regimen (number of daily insulin injections or insulin pump use). 
Routinely collected hospital administrative data on age, sex, ethnicity and area of residence 
(used to calculate small area deprivation measures) were obtained from the hospital data 
systems. These analyses are restricted to participants who had had HbA1c measured within 
our clinic between the ages of 9.0 to 17.99 years in 2008 to 2013 inclusive.  
Measures 
HbA1c was measured at each visit using the point of care Siemens/Bayer DCA 2000+ 
Analyzer. Values reported as being above the upper end of the instrument’s range (i.e. >130 
mmol/mol(14%)) were assigned a value of 130mmol/mol (14.0%) in these analyses. Note 
that all clinic patients are routinely tested for abnormal haemoglobins, and HbA1c is not 
measured in this group.  
Ethnicity was obtained from parental self-report at time of registration with the clinic using a 
non-standardised National Health Service typology. Parents could identify their child as 
white, “British”, black British, Asian British, multiple categories of mixed ethnicity or as 
belonging to a particular ethnic group. Due to a lack of precision (e.g. the “British” group 
likely included small numbers of non white young people identifying as British separately to 
those identifying as black British or Asian British), we dichotomised the sample into those 
identifying as white or ‘British’ (white or British group (85.9%)) and those identifying with 
non-white ethnic groups (non-white (n=53; 14.1%)).  The latter group included 29 identifying 
as black or African, 14 from south Asian ethnic groups, with the remainder of mixed or other 
ethnicity.  
Socioeconomic status measured using the UK Index of Multiple Deprivation (IMD) 2010, 
which provides a relative measure of deprivation across seven domains for small areas in 
England. IMD rank scores were assigned to quintiles using national thresholds, with 5 being 
the least deprived and 1 being the most deprived.(20) For the growth mixture models, a 
binary measure was used taking deprivation to be the most deprived (1st) quintile. 
Treatment type (number of insulin injections or CSII use) was recorded at each time point. 
For analysis, treatment was classified as CSII or injection regimens due to very low numbers 
in our clinic using <4 injections per day. For each individual using CSII, the date of initiation 
of CSII was the first point at which the patient was coded as being on a CSII regimen.  
We used the annual number of clinic visits where an HbA1c was recorded (i.e. total visits 
between 2008 & 2013 divided by time in follow-up for each patient) as a proxy for health 
service use for each patient.  
Analyses 
To assess average growth trajectories across the sample, following Singer & Willetts(21) we 
constructed a series of multi-level models for change using the xtmixed commands in Stata 
13. We began with unadjusted growth models using age as the temporal metric. Age was 
centred on age 9 for analyses. We then tested the association of demographic factors such 
as sex and duration of diabetes in the models. We then sequentially added our hypothesized 
predictors using the Aikake information criterion (AIC) and sample-adjusted Bayesian 
information criterion (BIC) at each step to judge model performance compared with 
previous models. In this we first added time invariant predictors i.e. deprivation (by 
quintile), ethnicity (white or British versus non-white) and number of clinic visits 
(continuous). We then added CSII use as a time-varying predictor. At each step, quadratic 
terms and interactions were examined and included in models only where significant and 
where they improved model fit. Terms were tested for significance in subsequent models if 
p value <0.1 in the previous model iteration. 
Growth mixture modeling was undertaken using the mixture commands in MPlus 7.1 
(www.statmodel.com). Models used maximum likelihood estimation with robust standard 
errors to account for missing data, with 500 random starts used in each model for 
maxiumum likelihood optimization; this was sufficient in all models to replicate the best log-
likelihood ratio. We began with a single trajectory model and sequentially increased 
trajectory number, assessing model fit at each step using the AIC, sample adjusted BIC,  
entropy and the Vuong-Lo-Mendell-Rubin test. The latter was used to test fit with k classes 
compared to a model with k-1 classes; a p-value <0.05 rejects the k − 1 class model in favour 
of the k class model.(22) As suggested by the literature, we judged the best model on the 
basis of clinical plausibility and model fit criteria.(16) Having identified the best mixture 
model, we then examined the effects of our hypothesized predictors on an individual’s 
likelihood of belonging to one of the trajectory classes using the mixture commands in 
MPlus.  
 
  
Results 
2560 HbA1c datapoints were available on 384 patients with T1D (193 (50.4%) female) from 
January 2008 to December 2013. The average number of HbA1c clinic datapoints per patient 
was 6.7 (range 1 to 21), with mean time spent in the clinic being 4.0 (SD 1.65) years (range 
0.05 to 6.0 years).  Median number of annual visits was 3.1 (IQR: 2.5, 3.8). Demographic 
characteristics of the sample are shown in Table 1, together with last-recorded treatment 
regimen (as this changed across the study period).  
The sample was well distributed across deprivation quintiles in both sexes, with minor 
under-representation of the most deprived quintile. At entry to the cohort, 40.5% were 
using CSII, with 68.0% using CSII as their last recorded regimen. The remainder were all on 
multiple daily injection (MDI) regimens. Year of diagnosis was available in 358 participants, 
with median year of diagnosis being 2005 (range 1994 to 2013; IQR 2002-2008).  
There were no differences between sexes in ethnicity, treatment regimen or deprivation. 
Deprivation and ethnicity were strongly associated with regimen. 92% (n=11) of those using 
twice daily insulin and 52.2% (82) of those using MDI were in the most deprived population 
quintile compared with 18.4 (38) of those using CSII (p<0.0001). 23.7% (40) of those using 
injection regimens were non ‘white/British’ compared with 6.3% (13) of those using CSII 
(p<0.0001).  
Multi-level growth models  
An unadjusted growth model for time showed that mean HbA1c for the clinic decreased over 
time from 2008 to 2013 by 0.122% (95% CI: 0.034, 0.210; p=0.007) per year. As age and time 
are the same metric and thus collinear in any model, subsequent models used age as the 
metric, centred on age 9.  
Sequential multi-level models for change in HbA1c with increasing age from 9 to 18 years are 
shown in Table 2. Model A, the unadjusted growth model, shows that mean HbA1c increased 
significantly with age; due to the larger linear coefficient and smaller quadratic coefficient, 
within the age-range of the model the increase tapered and ceased at age 18 years. Sex was 
not associated with mean HbA1c. Duration of diabetes was also not significantly associated 
with mean HbA1c (p=0.1) and sex and duration were not included in further models. The best 
model (lowest model fit criteria) was Model E. There was a significant main effect for CSII 
but no significant interaction of CSII and age. This meant that, for each individual, transition 
from injection to CSII treatment was associated with a mean decrease in HbA1c of 0.6% at 
the time of initiation, however subsequently remaining on CSII was not associated with 
greater or lesser change in HbA1c than for those on injections i.e. greater duration of CSII did 
not influence HbA1c. In this model, linear and quadratic age terms, ethnicity, visits and the 
interaction of visits and age each remained significant however the effect of deprivation was 
entirely attenuated. We identified no significant interactions of ethnicity with insulin 
regimen, visits or deprivation. Time in follow-up was not a significant predictor of HbA1c 
when added to the model including CSII, and was thus not included in the final model. 
 
Growth mixture models 
Table 3 shows sequential growth mixture models for change in HbA1c from age 9 to 17 years, 
commencing with specification of a single class through to specification of 4 classes. The 
table shows the entropy and change in AIC, BIC for each model together with the 
proportions of the sample in each trajectory class and the values and significance of the 
intercepts, linear slope and quadratic slope for each class.  
Improvements in AIC and BIC suggested that the 4 class model was the best fit with the data 
and we deemed it the most clinically plausible. The 4 class model is shown graphically in 
Figure 1. The largest group are those who maintain good control throughout adolescence, 
showing a slight but temporary deterioration in early adolescence (Good Control group, 
45.1%). The second largest group are those in whom control deterioriates in a linear fashion 
across adolescence (Deterioriating Control group, 39.6%). In a much smaller group, control 
deteriorated rapidly across early adolescence before improving in later adolescence, 
reflecting the significant quadratic term in the model (Rapidly Deteriorating Control group, 
6.5%). The final group were those who maintained poor control across adolescence (Poor 
Control, 8.8%)  
We then examined which factors predicted an individual’s membership of the HbA1c 
trajectory classes in the final 4 class mixture (Table 4). Sex and duration did not predict 
trajectory membership. The best model included deprivation, ethnicity, visits and CSII use, 
however regimen became the only significant predictor in the model with the effects of 
deprivation, ethnicity and visits all attenuated. CSII use was associated with protection 
against being in all other trajectory groups compared with being in the Good Control group.  
 
  
Discussion 
We found that ethnicity, frequency of health service use and insulin pump use influenced 
the average trajectory of HbA1c across adolescence and that insulin regimen influenced an 
individual’s pattern of HbA1c change across adolescence.  
The average trajectory for HbA1c was to increase across early adolescence to a peak in late 
adolescence and decrease thereafter. We found that deprivation had no effect on HbA1c 
when insulin regimen was introduced into the model, suggesting that the mechanism by 
which deprivation influences glycaemic control in our sample is through poor access to 
intensive insulin therapies. In contrast, non-white ethnicity exerted an effect on HbA1c 
independently of insulin regimen, health service use or deprivation. Whilst minority 
ethnicity young people had much lower CSII use in our sample, we identified no significant 
interactions of ethnicity with insulin regimen, visits or deprivation. Our findings suggest that 
whilst young people from minority groups do have poorer access to CSII, ethnicity also 
impacts upon diabetes control through cultural and behavioural factors unrelated to 
deprivation, frequency of health service use or access to pump therapy.  
These findings relate to the average growth trajectory of our sample across adolescence. 
However, we found that a 4 class mixture model best fitted our data, suggesting that young 
people fit into 4 clinically plausible patterns of HbA1c change across adolescence. Around half 
our sample maintained an excellent HbA1c (≤58mmol/mol (7.5%)) with minimal change 
across adolescence (Good control trajectory). The second largest group showed gradual 
deterioration of control across adolescence (Deteriorating control trajectory). The smallest 
group experienced a dramatic deterioration in early adolescence with later improvement 
((Rapidly deteriorating control trajectory), whilst around 10% maintained poor control 
across adolescence (Poor control trajectory). Insulin regimen was the only significant 
predictor of trajectory group membership. The apparent protective effect of CSII against 
being in the Poor Control trajectory may relate to reverse causality, as those in poor control 
in early adolescence are rarely considered clinically good candidates for offer of CSII. 
However this is unlikely to be the case with either of the deteriorating control trajectories. 
Taken together these growth and mixture models suggest that access to CSII is the strongest 
predictor of HbA1c across adolescence. CSII initiation was associated with a fall in HbA1c that 
was maintained across adolescence, and CSII was protective against being in trajectories of 
deteriorating HbA1c across adolescence.  
Comparison with the literature 
Our study is unique in studying longitudinal predictors of glycaemic trajectories in UK 
children and adolescents and in modeling the independent effects of deprivation, ethnicity, 
insulin regimen and health service use.  
Studies from the USA, New Zealand and Denmark each reported an association between 
minority ethnicity and poorer HbA1c over time,(4, 13, 23) although associations with 
deprivation were inconsistent. Little data is available on the impact of insulin regimen 
intensification on the association of ethnicity and diabetes control. In an observational study 
of insulin intensification in one London clinic, intensification appeared to benefit white 
young people the most, with little benefit for ethnic minority groups.(24) 
The few previous studies of trajectories of diabetes control across adolescence have all been 
small US studies drawn from largely white high socioeconomic status research samples and 
focused on psychosocial predictors of diabetes control across adolescence.(17-19, 25) None 
have modeled the combined impact of structural factors including ethnicity, health service 
use or deprivation on trajectory membership. We identified 4 discrete trajectories of control 
across adolescence, in comparison to previous studies which identified 2(19, 25) or 3(17, 18) 
trajectory groups. Our findings were similar to that of Rohan et al., who found the majority 
in stable good control, with a large group beginning in moderate control that gradually 
deteriorated across adolescence and a small group with persistent poor control across 
adolescence.(17) However we also identified a fourth group i.e. those with rapidly 
deteriorating control. The impact of insulin regimen on trajectory was only examined by one 
study, who also found that CSII use was protective against deteriorating control 
trajectories.(25) 
Strengths and limitations 
We used two advanced statistical techniques to provide different perspectives on change in 
HbA1c over time in individuals using all available data. Mixture modelling techniques used 
and criteria for determining model fit and trajectory class number were taken from mixture 
modelling best practice(22) and are similar to those used in other trajectory analyses in 
adolescent diabetes.(18, 19) Whilst our sample was from a single high performing large 
clinic, it is similar to the UK population in terms of socioeconomic status, ethnically diverse 
and has a range of insulin regimens in use. Our sample is the largest thus far used in growth 
mixture modelling in diabetes.  
Our data are subject to a number of limitations. We used DCA data which provide a ceiling 
effect for HbA1c , as we assigned any with value >130mmol as being 130mmol/mol. This 
affected a very small number of datapoints (n=79; 2%). Ethnicity was self-assigned and our 
categories (white or British versus identifying as non-white ethnic group) are not directly 
comparable to standard ethnicity classifications. However, our categorization distinguishes 
those who identify with an ethnic minority group from those who identify with British 
culture. Whilst we used best available methods to identify trajectory groups in the mixture 
modelling, it is important to recognise that mixture modelling is an exploratory technique 
and it is possible that chance relationships in our data may influence trajectory group 
findings.(26) However the trajectory groups we identified were similar to those found in 
other studies and were clinically plausible.  
 
Conclusions 
Change in HbA1c across adolescence is influenced by ethnicity, insulin regimen and health 
service use.  Deprivation influences glycaemic control largely through poor access to 
intensive insulin therapies. Increasing uptake of insulin pump use and ensuring access to 
health services are likely to be the most effective means of reducing inequalities in 
outcomes of T1D in children and young people.  
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Table 1. Demographic and clinical characteristics of participants 
 
    Males Females Total 
Mean age across all visits                
mean (SD) 
  13.4 (2.4) 13.5 (2.5) 13.3 (2.5) 
Mean age first visit in this 
sample (SD) 
 12.5 (2.6) 12.5 (2.6) 12.5 (2.6) 
Insulin regimen     % (n) 2 injections per day 3.7 (7) 2.6 (5) 3.2 (12) 
 
Multiple daily injections 40.6 (76) 43.2 (82) 41.9 (158) 
 
CSII 55.6 (104) 54.2 (103) 54.9 (207) 
    
   
Ethnicity                % (n) white or British 87.1 (163) 84.7 (160) 14.1 (53) 
 
Non ‘white’ 12.8 (24) 15.3 (20) 85.9 (323) 
    
   
Socioeconomic  status: IMD  1 (most deprived) 14.4 (27) 15.9 (30) 15.2 (57) 
quintile    % (n) 2 19.8 (37) 19.6 (37) 19.7 (74) 
 
3 21.4 (40) 20.1 (38) 20.7 (78) 
 
4 25.1 (47) 25.4 (48) 25.3 (95) 
  5 (least deprived) 19.3 (36) 19.0 (36) 19.2 (72) 
 
     
N for IMD = 376; N for ethnicity = 376; N for insulin regimen = 377    
 
 
 
 
 
Table 2.  Multilevel model for change in HbA1c with age   
Model A: growth model Model B: add deprivation Model C: add ethnicity Model D: add visits Model E: add CSII 
treatment 
 
  B (95% CI) p B (95% CI) p B (95% CI) p B (95% CI) p B (95% CI) p 
Constant / Intercept   7.754 
 
7.989 
 
8.524 
 
8.453 
 
8.692 
 
Age (centred on 9 years) linear 0.315 (0.205, 0.424) <0.0001 0.334 (0.223, 0.445) <0.0001 0.335 (0.224, 0.447) <0.0001 0.478 (0.353, 
0.603) 
<0.0001 0.388 (0.268, 
0.508) 
<0.0001 
 
quadratic -0.019 (-0.032, -
0.006) 
0.003 -0.022 (-0.034, -
0.009) 
0.001 -0.022 (-0.034, -
0.009) 
0.001 -0.023 (-0.035, -
0.010) 
0.001 -0.016 (-0.028, -
0.005) 
0.006 
index of multiple 
deprivation (IMD) quintile 
1 
  
0 
 
0 
 
0 
 
0 
 
 
2 
  
-0.048 (-0.564, 0.468) 0.9 0.008 (-0.513, 
0.528) 
0.9 -0.102 (-0.582, 
0.378) 
0.7 -0.070 (-0.558, 
0.416) 
0.8 
 
3 
  
-0.261 (-0.747, 0.225) 0.3 -0.118 (-0.623, 
0.387) 
0.6 -0.184 (-0.647, 
0.289) 
0.4 -0.007 (-0.481, 
0.465) 
0.9 
 
4 
  
-0.457 (-0.907, -
0.008) 
0.046 -0.277 (-0.753, 
0.198) 
0.3 -0.288 (-0.729, 
0.153) 
0.2 -0.181 (-0.633, 
0.265) 
0.4 
 
5  
  
-0.659 (-1.141, -
0.176) 
0.007 -0.476 (-0.998, 
0.047) 
0.07 -0.534 (-1.037, -
0.031) 
0.04 -0.323 (-0.823, 
0.176) 
0.2 
 
Effect of IMD on change with age 
 
- 
       
Ethnicity non-white 
    
0 
   
0 
 
 
white or British 
    
-0.769 (-1.318, -
0.220) 
0.006 -0.714 (-1.209, -
0.220) 
0.005 -0.737 (-1.247, -
0.227) 
0.005 
 
Effect of ethnicity on change with 
age 
   
- 
 
- 
 
- 
 
Number of visits per year Visits 
      
0.006 (-0.001, 
0.012) 
0.08 0.009 (0.002, 
0.080) 
0.003 
 
Effect of visits on change with age 
     
-0.016 (-0.022, -
0.011) 
<0.0001 -0.012 (-0.018, -
0.006) 
<0.0001 
CSII treatment Injection regimen 
        
0 
 
 
Pump user 
        
-0.578 (-0.769, -
0.389) 
<0.0001 
 
Effect of CSII on change with age 
       
- 
 
Model sample size (N)   2560 
 
2559 % 
change 
2558 % 
change 
2558 % 
change 
2274 % 
change 
Aikake information 
criterion (AIC) 
  7378.827 
 
7335.636 -0.6% 7322.352 -0.2% 7293.44 -0.4% 6080.70 -16.6% 
Bayesian information 
criterion (BIC) 
  7437.304 
 
7376.567 -0.8% 7369.127 -0.1% 7351.91 -0.3% 6143.72 -16.4% 
 
 
Notes: HbA1c is shown here only in NGSP units (%) as these were the units in which the models were run. BIC is sample-adjusted.
Table 3. Mixture models for HbA1c trajectories from age 9 to 17 years 
    
 
1 class model 
  
2 class model 
  
3 class model 
  
4 class model 
 
Number of classes specified  
 
1 
  
2 
  
3 
  
4 
 
Sample (N)   
 
386 
  
386 
  
386 
  
386 
 
Indicies of model fit 
            
AIC   
 
4346.975 
  
3919.457 
  
3735.817 
  
3634.71 
 
change in AIC from previous model 
    
-9.8% 
  
-4.7% 
  
-2.7% 
 
Sample adjusted BIC 
 
4356.371 
  
3931.984 
  
3751.476 
  
3653.501 
 
change in adjusted BIC from previous   
   
-9.7% 
  
-4.6% 
  
-2.6% 
 
Entropy   
    
0.847 
  
0.763 
  
0.784 
 
Proportions in each trajectory class Class N % Class N % Class N % Class N % 
    1 386 100% 1 78 20.2% 1 45 11.7% 1 34 8.8 
    
   
2 308 79.8% 2 145 37.6% 2 153 39.6 
    
      
3 196 50.8% 3 25 6.5 
    
         
4 174 45.1 
Vuong-Lo-Mendell-Rubin test  
 
N/A 
  
2 versus 1 
class 
  
3 versus 2 
classes 
  
4 versus 3 
classes 
 
 
  
    
p=0.0008 
  
p=0.09 
  
p=0.17 
 
    Mean SE p Mean SE p Mean SE p Mean SE p 
Class 1 Intercept 7.779 0.091 <0.0001 8.762 0.312 <0.00
01 
9.821 0.913 <0.0001 12.173 0.692 <0.0001 
  Linear slope 0.257 0.063 <0.0001 0.775 0.197 <0.00
01 
0.691 0.457 0.13 -0.597 0.281 0.05 
  Quadratic slope -0.012 0.009 0.17 -0.048 0.025 0.057 -0.045 0.047 0.3 0.057 0.031 0.07 
Class 2 Intercept 
   
7.586 0.101 <0.00
01 
8.349 0.123 <0.0001 8.409 0.116 <0.0001 
  Linear slope 
   
0.157 0.053 0.003 0.264 0.085 0.002 0.148 0.073 0.04 
  Quadratic slope 
   
-0.009 0.006 0.15 -0.018 0.012 0.146 -0.008 0.01 0.4 
Class 3 Intercept 
      
7.276 0.104 <0.0001 7.724 0.361 <0.0001 
  Linear slope 
      
0.127 0.052 0.015 1.739 0.271 <0.0001 
  Quadratic slope 
      
-0.014 0.006 0.023 -0.136 0.04 0.001 
Class 4 Intercept 
         
7.247 0.101 <0.0001 
  Linear slope 
         
0.103 0.051 0.04 
  Quadratic slope 
         
-0.012 0.006 0.04 
 
Notes : Table shows mixture models for 1 through to 4 classes of HbA1c trajectories. Model fit indices are shown together with % change from previous model with 1 fewer class, the proportions of the sample in 
each trajectory class in that model and class intercepts and slopes (linear and quadratic).   The Vuong-Lo-Mendell-Rubin test measures the superiority of the specified model compared to that with 1 fewer class. 
N/A= not available. 
HbA1c is shown here only in NGSP units (%) as these were the units in which the models were run. 
Figure 1. Graphical representation of the 4 class mixture model for HbA 1c trajectories from age 9 to 
17 years 
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Poor control: 8.8%
Rapidly deteriorating control : 6.5%
Deteriorating control: 39.6%
Good control:  45.1%
Table 4. Predictor model for membership of HbA1c trajectory class in the final 
4 class mixture model 
 
  Model including Deprivation, 
Ethnicity & Visits 
Model including Deprivation, Ethnicity, 
Visits & CSII 
N   
  
384 
   
372 
 
AIC   
  
3609.902 
   
3458.119 
 
Sample adjusted BIC 
  
3640.236 
   
3490.952 
 
Deprivation: bottom quintile v others B SE OR p B SE OR p 
  Good control 0 
 
1 
 
0 
 
1 
 
  Poor control 0.051 0.879 1.05 0.9 0.300 0.686 1.35 0.7 
  Deterioriating control 0.652 0.476 1.92 0.17 0.263 0.469 1.30 0.6 
  Rapidly deterioriating control 1.446 0.542 4.25 0.008 0.844 0.609 2.33 0.17 
Ethnicity: white or British v non-white 
        
  Good control 0 
 
1 
 
0 
 
1 
 
  Poor control -2.706 0.994 0.07 0.007 -0.060 0.773 0.94 0.9 
  Deterioriating control 0.387 0.674 1.47 0.6 0.585 0.469 1.79 0.2 
  Rapidly deterioriating control -1.719 0.614 0.18 0.005 -0.926 0.609 0.40 0.13 
Visits (continuous) 
        
  Good control 0 
 
1 
 
0 
 
1 
 
  Poor control 0.129 0.111 1.14 0.2 0.054 0.066 1.06 0.4 
  Deterioriating control 0.019 0.04 1.02 0.6 0.067 0.04 1.07 0.10 
  Rapidly deterioriating control -0.176 0.064 0.84 0.006 -0.12 0.073 0.89 0.10 
Insulin Regimen: CSII v. MDI 
        
  Good control 
    
0 
 
1 
 
  Poor control 
    
-3.244 0.96 0.04 0.001 
  Deterioriating control 
    
-1.724 0.449 0.18 <0.0001 
  Rapidly deterioriating control 
    
-2.331 0.652 0.10 <0.0001 
 
Table shows coefficients (B), standard errors (SE) and p-values for regression of trajectory 
group membership on each predictor, with exponentiated coefficients (Odds ratios, OR). 
Model fit criteria (AIC and BIC) also shown.  
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